{"id":837775,"date":"2025-04-15T17:03:40","date_gmt":"2025-04-15T21:03:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/"},"modified":"2025-04-15T17:03:40","modified_gmt":"2025-04-15T21:03:40","slug":"organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/","title":{"rendered":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors<\/b><\/p>\n<p>JERSEY CITY, N.J.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nOrganon (NYSE: OGN) a global healthcare company with a focus on women\u2019s health, today announced the appointment of Ramona A. Sequeira, President of the Global Portfolio Division at Takeda Pharmaceutical Company, to Organon\u2019s Board of Directors, effective July 1, 2025. Ms. Sequeira will serve on the Board\u2019s Talent Committee. In connection with Ms. Sequeira\u2019s appointment, the size of Organon\u2019s Board will be expanded to 12 directors.\n<\/p>\n<p>\nMs. Sequeira brings more than 30 years of pharmaceutical industry expertise, with 20 years at Eli Lilly and Company and 10 years at Takeda. She is a proven commercial leader with a steadfast commitment to building strategies around the needs of patients and a track record of strong execution across global markets including the USA, Europe and Emerging Markets.\n<\/p>\n<p>\n\u201cWe are excited to strengthen our Board with the appointment of Ramona Sequeira,\u201d said Carrie Cox, Chairman of Organon\u2019s Board of Directors. \u201cHer deep experience in commercial strategy will be a valuable asset to Organon as we continue to seek growth opportunities for our expansive and diverse portfolio.\u201d\n<\/p>\n<p>\nIn her role as President of the Global Portfolio Division, Ms. Sequeira sits on Takeda\u2019s Global Executive Team and is responsible for leading business units across Europe and Canada, China and Growth and Emerging Markets\u2013 in addition to Takeda\u2019s Vaccines Business Unit and Global Medical and Commercial Strategy functions. She co-chairs Takeda\u2019s Pipeline Review Committee and previously led Takeda\u2019s US business. Prior to joining Takeda, Ms. Sequeira held senior roles at Eli Lilly, including General Manager of Lilly UK and Northern Europe and Vice President of Lilly USA. She was the first woman to Chair the Pharmaceutical Research and Manufacturers of America Board of Directors and served on the Board of the Association of the British Pharmaceutical Industry. Ms. Sequeira is currently a member of the Board of Directors of Edwards Life Sciences. She received a Bachelor of Science with honors in molecular genetics and molecular biology from the University of Toronto and an MBA from McMaster University in Canada.\n<\/p>\n<p><b>About Organon<\/b><\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.organon.com%2F&amp;esheet=54238619&amp;newsitemid=20250415558806&amp;lan=en-US&amp;anchor=Organon&amp;index=1&amp;md5=40eb059e0a755191a466725d7f71c87e\">Organon<\/a> is an independent global healthcare company with a mission to help improve the health of women throughout their lives. Organon\u2019s diverse portfolio offers over 70 medicines and products in women\u2019s health, biosimilars, and a large franchise of established medicines across a range of therapeutic areas. In addition to Organon\u2019s current products, the company invests in innovative solutions and research to drive future growth opportunities in women\u2019s health and biosimilars. Organon is also pursuing opportunities to collaborate with biopharmaceutical partners and innovators who look to commercialize their products by leveraging Organon\u2019s scale and agile presence in fast growing international markets.\n<\/p>\n<p>\nOrganon has geographic scope with significant reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.\n<\/p>\n<p>\nFor more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.organon.com%2F&amp;esheet=54238619&amp;newsitemid=20250415558806&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.organon.com%2F&amp;index=2&amp;md5=6c95ad8b97d97d6bc6437a156f79e9d2\">https:\/\/www.organon.com\/<\/a> and connect with us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Forganon%2F&amp;esheet=54238619&amp;newsitemid=20250415558806&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=b44919e1bcd80e2cf91b20246df0ea93\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Forganonllc%2F&amp;esheet=54238619&amp;newsitemid=20250415558806&amp;lan=en-US&amp;anchor=Instagram&amp;index=4&amp;md5=8932b793f2b068aeac3168fd94616531\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FOrganonLLC&amp;esheet=54238619&amp;newsitemid=20250415558806&amp;lan=en-US&amp;anchor=X+%28formerly+known+as+Twitter%29&amp;index=5&amp;md5=d8a1660e1468a925abae49465fb2fc63\">X (formerly known as Twitter)<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FOrganonLLC&amp;esheet=54238619&amp;newsitemid=20250415558806&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=78b8fc6d0aad8389ead343683f114217\">Facebook<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250415558806\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250415558806\/en\/<\/a><\/span><\/p>\n<p>\nMedia Contacts:\n<\/p>\n<p>\nFelicia Bisaro<br \/>\n<br \/>(646) 703-1807\n<\/p>\n<p>\nKate Vossen<br \/>\n<br \/>(732) 675-8448\n<\/p>\n<p>\nInvestor Contacts:\n<\/p>\n<p>\nJennifer Halchak<br \/>\n<br \/>(201) 275-2711\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America New Jersey<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Women Consumer Health Pharmaceutical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250415558806\/en\/1899940\/3\/Organon_logo_tagline.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors JERSEY CITY, N.J.&#8211;(BUSINESS WIRE)&#8211; Organon (NYSE: OGN) a global healthcare company with a focus on women\u2019s health, today announced the appointment of Ramona A. Sequeira, President of the Global Portfolio Division at Takeda Pharmaceutical Company, to Organon\u2019s Board of Directors, effective July 1, 2025. Ms. Sequeira will serve on the Board\u2019s Talent Committee. In connection with Ms. Sequeira\u2019s appointment, the size of Organon\u2019s Board will be expanded to 12 directors. Ms. Sequeira brings more than 30 years of pharmaceutical industry expertise, with 20 years at Eli Lilly and Company and 10 years at Takeda. She is a proven commercial leader with a steadfast commitment to building strategies around the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837775","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors JERSEY CITY, N.J.&#8211;(BUSINESS WIRE)&#8211; Organon (NYSE: OGN) a global healthcare company with a focus on women\u2019s health, today announced the appointment of Ramona A. Sequeira, President of the Global Portfolio Division at Takeda Pharmaceutical Company, to Organon\u2019s Board of Directors, effective July 1, 2025. Ms. Sequeira will serve on the Board\u2019s Talent Committee. In connection with Ms. Sequeira\u2019s appointment, the size of Organon\u2019s Board will be expanded to 12 directors. Ms. Sequeira brings more than 30 years of pharmaceutical industry expertise, with 20 years at Eli Lilly and Company and 10 years at Takeda. She is a proven commercial leader with a steadfast commitment to building strategies around the &hellip; Continue reading &quot;Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T21:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors\",\"datePublished\":\"2025-04-15T21:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/\"},\"wordCount\":560,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/\",\"name\":\"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-04-15T21:03:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors - Market Newsdesk","og_description":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors JERSEY CITY, N.J.&#8211;(BUSINESS WIRE)&#8211; Organon (NYSE: OGN) a global healthcare company with a focus on women\u2019s health, today announced the appointment of Ramona A. Sequeira, President of the Global Portfolio Division at Takeda Pharmaceutical Company, to Organon\u2019s Board of Directors, effective July 1, 2025. Ms. Sequeira will serve on the Board\u2019s Talent Committee. In connection with Ms. Sequeira\u2019s appointment, the size of Organon\u2019s Board will be expanded to 12 directors. Ms. Sequeira brings more than 30 years of pharmaceutical industry expertise, with 20 years at Eli Lilly and Company and 10 years at Takeda. She is a proven commercial leader with a steadfast commitment to building strategies around the &hellip; Continue reading \"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-15T21:03:40+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors","datePublished":"2025-04-15T21:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/"},"wordCount":560,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/","name":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-04-15T21:03:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250415558806r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Organon Appoints Ramona A. Sequeira to the Company\u2019s Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837775"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837775\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}